<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">It has been recommended that in selecting plant medicines for cancer treatment, ethnopharmacological uses in cancer-relevant diseases such as inflammation, infection, and immune and skin disorders should be taken into account
 <sup>
  <xref ref-type="bibr" rid="CR19">19</xref>
 </sup>. In the present investigation, polygonumins A, a novel compound isolated from the stem of 
 <italic>P</italic>. 
 <italic>minus</italic>, was first evaluated for its antiproliferative activities against HCT116, C33A, H1299, MCF7, A549, and K-562 cancer cell lines using the MTT assay and then for its activities in radical scavenging and acetylcholinesterase inhibition. The activity towards HIV-1 protease inhibitor was also evaluated, as the newly isolated compound has a structure similar to that of vanicoside A.
</p>
